bluebird bio Inc.

NASDAQ: BLUE · Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM

bluebird bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
62.3M 221.75M 113.01M 161.16M
Short-Term Investments
n/a n/a 67.32M 138.34M
Long-Term Investments
n/a n/a 1.41M 97.11M
Other Long-Term Assets
52.64M 54.34M 52.13M 53.28M
Receivables
3.09M 13.01M 10.79M 11.39M
Inventory
65.02M 22.92M -1.41M -108.5M
Other Current Assets
13.62M 9.2M n/a n/a
Total Current Assets
154.67M 281.69M 199.49M 336.52M
Property-Plant & Equipment
237.73M 267.05M 291.36M 101.24M
Goodwill & Intangibles
15.19M 16.08M 10.51M 5.65M
Total Long-Term Assets
305.56M 337.48M 355.41M 257.27M
Total Assets
460.23M 619.16M 554.9M 593.79M
Account Payables
34.32M 18.5M 14.87M 25.88M
Deferred Revenue
n/a n/a 1.5M 2.28M
Short-Term Debt
71.51M n/a n/a 23.15M
Other Current Liabilities
19.5M 55.74M 31.87M 37.43M
Total Current Liabilities
321.46M 200.11M 128.24M 152.99M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
947K 92K 92K 93K
Total Long-Term Liabilities
170.3M 224.51M 230.32M 66.53M
Total Liabilities
491.77M 424.62M 358.56M 219.52M
Total Debt
358.24M 330.33M 281.39M 89.58M
Common Stock
1.92M 1.91M 830K 711K
Retained Earnings
-4.5B -4.26B -3.99B -3.72B
Comprehensive Income
-2.13M -1.8M -4.07M -2.91M
Shareholders Equity
-31.53M 194.54M 196.34M 374.28M
Total Investments
n/a 8.95M 68.73M 235.46M